Full-Body MRI | Luxury Science

Companies like Prenuvo have popularized full-body MRI scans as a wellness product—an hour in the scanner for a comprehensive look at everything. The promise is early detection and peace of mind. But medical imaging specialists have raised pointed questions about sensitivity tradeoffs, reading time, missed findings, and the psychological effects of a "clean" scan that may not be as clean as it appears.

The Technical Challenges

A full-body scan covers enormous territory in limited time. Protocol choices involve tradeoffs: faster sequences mean lower resolution; broader coverage means less time per organ. A dedicated cardiac MRI or brain MRI uses optimized sequences for those specific structures. A full-body scan cannot achieve the same specificity for every system simultaneously.

Reading time matters too. A radiologist reviewing a targeted scan can spend 15-20 minutes on the relevant anatomy. A full-body scan contains vastly more images. The quality of interpretation depends not just on image quality but on attention per finding.

Why It Matters for Luxury

Full-body MRI represents a fascinating case where consumer demand has outpaced evidence. The scans provide dramatic-looking images and the feeling of thoroughness. Whether they provide actionable, life-extending information is genuinely unknown. The luxury health market has decided not to wait for the evidence; consumers are running their own uncontrolled experiment.

News & Coverage

Prenuvo Launches 10-Year, 100,000 Participant Study — Company announces largest clinical study of whole-body MRI screening effectiveness, seeking to build evidence base for general population screening — June 2024
Prenuvo Launches FDA-Cleared AI-Powered Products — FDA clears AI-powered body composition report; enhanced screening option now $4,500 including MRI, blood tests, and brain health assessment — February 2025
Washington Post: Prenuvo Full Body MRI Missed Stroke Signs — High-profile lawsuit alleges $2,500 scan failed to document \"abrupt focal 60% narrowing\" of middle cerebral artery; patient later suffered catastrophic stroke requiring three brain surgeries — January 2026
Prenuvo Loses Bid to Limit Damages — New York court rejects company's attempt to apply California malpractice damage caps to New York-based case — December 2025
Fred Hutch: \"Jury Still Out\" on Whole-Body MRI — Major cancer center notes breast portion of Prenuvo exam lacks IV contrast; Fred Hutch and UW Medicine do not offer this type of examination — August 2025

Research

Whole-body MRI for Preventive Health Screening: A Systematic Review of the Literature — December 2019
Kwee RM, Kwee TC. Journal of Magnetic Resonance Imaging, 50(5), 1489-1503, 2019. DOI: 10.1002/jmri.26736
This systematic review of 12 studies with 5,373 asymptomatic subjects found pooled prevalences of critical and indeterminate incidental findings of 32.1%, while histologically confirmed cancers occurred in only 1.5% of screened subjects. The high rate of findings requiring follow-up directly addresses the "incidentaloma" problem central to whole-body MRI screening debates.
Observations Regarding the Detection of Abnormal Findings Following a Cancer Screening Whole-Body MRI in Asymptomatic Subjects: The Psychological Consequences and the Role of Personality Traits Over Time — September 2024
Conti L, Mazzoni D, et al. Journal of Magnetic Resonance Imaging, 61(2), 634-645, 2025. DOI: 10.1002/jmri.29461
This prospective study of 121 asymptomatic adults found that 100% of participants had abnormal findings on whole-body MRI, with most classified as low-risk (ONCO-RADS 2). The research examines the psychological burden of receiving abnormal findings, a key concern when marketing scans to healthy individuals seeking reassurance.
Oncologically Relevant Findings Reporting and Data System (ONCO-RADS): Guidelines for the Acquisition, Interpretation, and Reporting of Whole-Body MRI for Cancer Screening — March 2021
Petralia G, Koh DM, Attariwala R, et al. Radiology, 299(3), 494-507, 2021. DOI: 10.1148/radiol.2020201723
This paper establishes standardized guidelines for interpreting whole-body MRI findings in cancer screening, acknowledging the need for consistent reporting given the high variability in how radiologists categorize incidental findings. The existence of such guidelines reflects ongoing efforts to impose rigor on a screening approach that currently lacks standardization.